Want to join the conversation?
Opdivo sales were just over $300MM in 3Q15, reflecting a strong uptake in squamous lung cancer and melanoma, particularly in the US, but also in Germany. Following the recent approval of non-squamous non-small cell lung cancer based on the 057 study, $BMY expects to be in an even more competitive position in the US.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)